Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: Selatogrel Outcome Study in Suspected Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction is a Phase 3 trial evaluating selatogrel for suspected heart attack. The study is currently en…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selatogrel (selatogrel)

Snippet

Sponsor: Viatris Innovation GmbH | Conditions: Acute Myocardial Infarction | Phase 3 | Status: ENROLLING_BY_INVITATION